Anticorps Recombinant de lapin anti-KMT2C

KMT2C Recombinant Antibody for IF/ICC, FC (Intra), ELISA

Hôte / Isotype

Lapin / IgG

Réactivité testée

Humain

Applications

IF/ICC, FC (Intra), ELISA

Conjugaison

Non conjugué

CloneNo.

240542A2

N° de cat : 83595-4-PBS

Synonymes

MLL3, 240542A2, HALR, Homologous to ALR protein, KIAA1506



Informations sur le produit

83595-4-PBS cible KMT2C dans les applications de IF/ICC, FC (Intra), ELISA et montre une réactivité avec des échantillons Humain

Réactivité Humain
Hôte / Isotype Lapin / IgG
Clonalité Recombinant
Type Anticorps
Immunogène KMT2C Protéine recombinante Ag28875
Nom complet myeloid/lymphoid or mixed-lineage leukemia 3
Masse moléculaire calculée 541 kDa
Numéro d’acquisition GenBankNM_170606
Symbole du gène KMT2C
Identification du gène (NCBI) 58508
Conjugaison Non conjugué
Forme Liquide
Méthode de purification Protein A purfication
Tampon de stockage PBS only
Conditions de stockageStore at -80°C. 20ul contiennent 0,1% de BSA.

Informations générales

Lysine (K)-specific methyltransferase 2C (KMT2C, also known as MLL3) belongs to the mixed-lineage leukemia (MLL) family of histone methyltransferases which methylate the histone 3 tail at lysine 4 (H3K4) as part of the complex proteins associated with Set 1 (COMPASS) complex. Although originally identified as oncogenic fusions in leukemia, genome-wide mutation studies have revealed frequent, presumably loss-of-function, mutations in various members of the MLL family, including MLL2/KMT2B, MLL3/KMT2C, and MLL4/KMT2D in a variety of malignancies, particularly solid tumors. Mechanistic studies of KMT2C in normal cells have focused primarily on its role in enhancer regulation by deposition of H3K4me1 marks.

{{ptg:RelatedPrimaryAntibodies}}